Attached files
| file | filename |
|---|---|
| EX-3.5 - EX-3.5 - INVO Bioscience, Inc. | ex3-5.htm |
| 8-K - 8-K - INVO Bioscience, Inc. | invobio8k010617.htm |
EXHIBIT 16.2
RBSM LLP
NEW YORK, NEW YORK
January 6, 2017
Securities and Exchange Commission
100 F Street, N.W.
Washington, DC 20549-7561
Dear Sirs/Madams:
We have read Item 4.01 of INVO Bioscience, Inc. (the “Company”) Form 8-K dated January 6, 2017, and are in agreement with the statements relating only to RBSM LLP contained therein. We have no basis to agree or disagree with other statements of the Company contained therein
Very truly yours,
/s/ RBSM LLP